IF by specialty › Rheumatology
The Lancet Rheumatology — Impact Factor
The 2025 Impact Factor of The Lancet Rheumatology is 29.5 (Q1 in Rheumatology; subscription or hybrid).
- Impact Factor
- 29.5 JCR 2025
- JCR category
- Rheumatology
- Quartile
- Q1 in Rheumatology
- Publisher
- Elsevier (The Lancet Group)
- Open access
- subscription or hybrid
- IF source
- thelancet.com
Position within the field
Ranked 2 of the 33 journals in Rheumatology on this site (top 10%).
Rheumatology journals with a similar Impact Factor
- Nature Reviews Rheumatology IF 33.7
- Annals of the Rheumatic Diseases IF 24.0
- Arthritis & Rheumatology IF 9.9
- Osteoarthritis and Cartilage IF 9.2
- Best Practice & Research Clinical Rheumatology IF 7.0
- Arthritis Research & Therapy IF 5.4
About this value
The Journal Impact Factor of The Lancet Rheumatology (JCR 2025, released June 2026) is 29.5. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Rheumatology.